Switch theme
Sign up to access all valuation multiples
Biotalys NV is an agricultural technology company focused on addressing food protection challenges with proprietary protein-based biocontrol solutions and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply.
2013
65
LTM Revenue $3.2M
LTM EBITDA -$9.5M
$108M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Biotalys has a last 12-month revenue of $3.2M and a last 12-month EBITDA of -$9.5M.
In the most recent fiscal year, Biotalys achieved revenue of n/a and an EBITDA of -$12.0M.
Biotalys expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Biotalys valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | XXX | XXX | XXX |
| Gross Profit | n/a | n/a | XXX | XXX | XXX |
| Gross Margin | NaN% | NaN% | XXX | XXX | XXX |
| EBITDA | -$19.9M | -$12.0M | XXX | XXX | XXX |
| EBITDA Margin | -Infinity% | -Infinity% | XXX | XXX | XXX |
| Net Profit | -$24.4M | -$22.0M | XXX | XXX | XXX |
| Net Margin | -Infinity% | -Infinity% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Biotalys's stock price is EUR 3 (or $3).
Biotalys has current market cap of EUR 118M (or $127M), and EV of EUR 100M (or $108M).
See Biotalys trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $108M | $127M | XXX | XXX | XXX | XXX | $-0.60 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Biotalys has market cap of $127M and EV of $108M.
Biotalys's trades at 33.4x LTM EV/Revenue multiple, and -11.3x LTM EBITDA.
Analysts estimate Biotalys's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Biotalys and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $108M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | XXX | XXX |
| EV/EBITDA | -9.0x | XXX | XXX | XXX |
| P/E | -8.9x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -7.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpBiotalys's NTM/LTM revenue growth is n/a
Biotalys's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Biotalys's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Biotalys's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Biotalys and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | -40% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | n/a | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Hydratec Industries | XXX | XXX | XXX | XXX | XXX | XXX |
| Brazil Potash | XXX | XXX | XXX | XXX | XXX | XXX |
| Gujarat State Fertilizers & Chemicals | XXX | XXX | XXX | XXX | XXX | XXX |
| Sipef | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Biotalys acquired XXX companies to date.
Last acquisition by Biotalys was XXXXXXXX, XXXXX XXXXX XXXXXX . Biotalys acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Biotalys founded? | Biotalys was founded in 2013. |
| Where is Biotalys headquartered? | Biotalys is headquartered in Belgium. |
| How many employees does Biotalys have? | As of today, Biotalys has 65 employees. |
| Who is the CEO of Biotalys? | Biotalys's CEO is Mr. Kevin Helash. |
| Is Biotalys publicy listed? | Yes, Biotalys is a public company listed on BRU. |
| What is the stock symbol of Biotalys? | Biotalys trades under BTLS ticker. |
| When did Biotalys go public? | Biotalys went public in 2021. |
| Who are competitors of Biotalys? | Similar companies to Biotalys include e.g. Fertiglobe, Hydratec Industries, Brazil Potash, Gujarat State Fertilizers & Chemicals. |
| What is the current market cap of Biotalys? | Biotalys's current market cap is $127M |
| What is the current revenue of Biotalys? | Biotalys's last 12-month revenue is $3.2M. |
| What is the current EBITDA of Biotalys? | Biotalys's last 12-month EBITDA is -$9.5M. |
| What is the current EV/Revenue multiple of Biotalys? | Current revenue multiple of Biotalys is 33.4x. |
| What is the current EV/EBITDA multiple of Biotalys? | Current EBITDA multiple of Biotalys is -11.3x. |
| Is Biotalys profitable? | Yes, Biotalys is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
